Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

AIMS: Interferon‐free direct‐acting antiviral agent (DAA) regimens for chronic hepatitis C virus (HCV) patients have improved their health‐related quality of life (HRQOL). Currently, there are no published data assessing the impact of DAAs regimens without sofosbuvir on HRQOL. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Hiroki, Watanabe, Tsunamasa, Matsumoto, Nobuyuki, Hiraishi, Tetsuya, Nakano, Hiroyasu, Noguchi, Yohei, Hattori, Nobuhiro, Shigefuku, Ryuta, Yamashita, Masaki, Nakahara, Kazunari, Matsunaga, Kotaro, Okuse, Chiaki, Yotsuyanagi, Hiroshi, Tanaka, Atsushi, Suzuki, Michihiro, Itoh, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207024/
https://www.ncbi.nlm.nih.gov/pubmed/30483569
http://dx.doi.org/10.1002/jgh3.12052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207024/
https://www.ncbi.nlm.nih.gov/pubmed/30483569
http://dx.doi.org/10.1002/jgh3.12052

Ejemplares similares